ProPhase Labs, Inc. Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

Subsequent Events (Details)

Subsequent Events (Details)							12 Months Ended
Subsequent Events (Details)	Mar. 17, 2026 USD ($) payment	Mar. 16, 2026 USD ($) payment	Mar. 10, 2026 USD ($) day	Jan. 27, 2026 USD ($) day shares	Jan. 19, 2026 USD ($) $ / shares shares	Jan. 13, 2026 USD ($) day payment shares	Dec. 31, 2025 USD ($)	Dec. 31, 2024 USD ($)
Subsequent Event [Line Items]
Proceeds from issuance of note payable							$ 4,074,000	$ 9,862,000
Convertible promissory note
Subsequent Event [Line Items]
Discount, current							$ 157,000
Note \| Convertible promissory note \| Subsequent Event
Subsequent Event [Line Items]
Interest rate (as a percent)						10.00%
Aggregate principal amount						$ 240,000
Debt instrument, convertible, threshold percentage of stock price trigger						75.00%
Debt instrument, convertible, threshold trading days \| day						5
Proceeds from short-term debt						$ 190,000
Discount, current						40,000
Debt issuance costs						10,000
Periodic payment						$ 264,000
Number of periodic payments \| payment						4
Common stock issued (in shares) \| shares						80,000
January Labrys Note \| Convertible promissory note \| Subsequent Event
Subsequent Event [Line Items]
Interest rate (as a percent)				10.00%
Aggregate principal amount				$ 180,000
Debt instrument, convertible, threshold percentage of stock price trigger				80.00%
Debt instrument, convertible, threshold trading days \| day				10
Proceeds from short-term debt				$ 140,000
Discount, current				30,000
Debt issuance costs				$ 10,000
Common stock issued (in shares) \| shares				75,000
Debt instrument, convertible, period from issuance date (in days)				180 days
January Labrys Note \| Convertible promissory note \| Subsequent Event \| January Labrys SPA
Subsequent Event [Line Items]
Debt instrument, convertible, beneficial ownership limitation, percentage				4.99%
March Labrys Note \| Convertible promissory note \| Subsequent Event
Subsequent Event [Line Items]
Interest rate (as a percent)			10.00%
Aggregate principal amount			$ 78,000
Debt instrument, convertible, threshold percentage of stock price trigger			80.00%
Debt instrument, convertible, threshold trading days \| day			10
Proceeds from short-term debt			$ 55,000
Discount, current			13,000
Debt issuance costs			$ 10,000
Debt instrument, convertible, period from issuance date (in days)			180 days
March Labrys Note \| Convertible promissory note \| Subsequent Event \| March Labrys SPA
Subsequent Event [Line Items]
Debt instrument, convertible, beneficial ownership limitation, percentage			4.99%
First March Future Receipts Financing Agreement \| Loans Payable \| Subsequent Event
Subsequent Event [Line Items]
Aggregate principal amount		$ 116,000
Periodic payment		$ 6,444
Number of periodic payments \| payment		18
Proceeds from issuance of note payable		$ 77,000
Origination fee		$ 3,000
Second March Future Receipts Financing Agreement \| Loans Payable \| Subsequent Event
Subsequent Event [Line Items]
Aggregate principal amount	$ 314,600
Periodic payment	$ 11,236
Number of periodic payments \| payment	28
Proceeds from issuance of note payable	$ 211,200
Origination fee	$ 8,800
Generating ELOC \| Subsequent Event
Subsequent Event [Line Items]
Common stock issued (in shares) \| shares					549,105
Equity line of credit facility, maximum amount of sellable stock					$ 10,000,000.0
Generating ELOC \| Subsequent Event \| Prefunded Common Stock Purchase Warrant
Subsequent Event [Line Items]
Number of securities called by each warrant (in shares) \| shares					240,369
Exercise price (in dollars per share) \| $ / shares					$ 0.00